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Insight on issues that impede GC 
implementation 
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1) Can GC positively impact on ICU mortality? 
 
2) Is there a glycemic target band performance metric or 
level that can be assessed in real time that ensures and 
discriminates improved patient outcome?  
 
3) When should glycemic control performance be assessed? 
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SPRINT1 Glucontrol2 All 
Number of patients 784 933 1717 
Percentage of males 61.2 63.2 62.3 
Age of patients 65.0 [52.0 - 74.0] 65.2 [51.5 - 74.0] 65.0 [51.8 - 74.0] 
APACHE 2 score 18.0 [15.0 - 24.0] 15.0 [11.0 - 21.0] 17.0 [13.0 - 23.0] 
Cohort BG (mmol/L) 6.2 [5.3 - 7.4] 6.9 [5.8 - 8.4] 6.6 [5.6 - 8.1] 
Per-patient median BG (mmol/L) 6.3 [5.6 - 7.5] 6.9 [6.1 - 8.2] 6.6 [5.8 - 7.9] 
%BG in 4-7 mmol/L 66.8 49.8 56.4 
Data are in the form of median [inter-quartile range, IQR] where applicable. 
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Percentage of blood glucose levels within a specific glycemic 
band from start to the present day 
• Calculated per day and per patient 
• Accounts for BG levels and variability 
• Measures glycemic outcome and control performance 
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4.0-7.0 mmol/L 5.0-8.0 mmol/L 4.0-8.0 mmol/L 




• Intermediate levels 
• ∆ = 3 mmol/L 
• Intermediate levels 
• ∆ = 3 mmol/L 
• Intermediate levels 
• ∆ = 4 mmol/L 
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cTIB in 4.0 – 7.0 mmol/L 
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cTIB = 32.8% < 50% cTIB = 65.6% ≥ 50% 
 
cTIB = 83.6% ≥ 50% 
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cTIB = 32.8% < 70% cTIB = 65.6% < 70% 
 
cTIB = 83.6% ≥ 70% 
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cTIB ≥ t 
t = 50%, 60%, 70%, 80% 
→ different levels of GC performance 
→ discrimination of improved outcomes 
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ICU mortality Lived Died 
cTIB ≥ t  𝑁1 𝑁2 
cTIB < t  𝑁3 𝑁4 




𝑁𝑖 : number of patients. 
Ratio between odds of living given cTIB ≥ t and odds of living 
given cTIB < t 
 
𝑂𝐿𝑐𝑇𝐼𝐵≥𝑡 = 𝑁1/𝑁2  
 
𝑂𝐿𝑐𝑇𝐼𝐵<𝑡 = 𝑁3/𝑁4  
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Glycemic levels  
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cTIB ≥ 50% 
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Glycemic variability  
 cTIB in 4.0-7.0 mmol/L vs. cTIB in 4.0-8.0 mmol/L 
 tighter vs. wider glycemic band 
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Glycemic control performance  
 When can it be assessed? 
 
cTIB ≥ 50% cTIB ≥ 60% cTIB ≥ 70% cTIB ≥ 80% 
Glycemic control performance  
 When can it be assessed? 
 
→ After 3 days 
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Yes … 
 (1) Association 
  max. BG within an intermediate glycemic band 
  = increased OR = improved patient outcomes 
 
 (2) Causation 
  Previous randomized control trials 1,2  
  Physiological reasons 3 + others 
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1) Can GC positively impact on ICU mortality? 
1 Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin 
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2 Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive Insulin Therapy 
in the Medical ICU. N Engl J Med 2006, 354(5):449-461.  
3 Weekers F, Giulietti AP, Michalaki M, Coopmans W, Van Herck E, Mathieu C, Van den Berghe G: Metabolic, endocrine, and immune effects of stress 
hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003, 144(12):5329-5338. 31 
Yes… 
 cTIB 
• 1 metric to assess glycemic levels, glycemic variability 
and patient outcomes 
• 1 metric able to reproduce different previous results 
about GC assessment 
• 1 metric easily calculated in real-time 
→ 1 metric to rule them all! 
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2) Is there a glycemic target band performance metric or level 
that can be assessed in real time that ensures and 
discriminates improved patient outcome? 
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Yes… 
 4.0-7.0 mmol/L = increased OR = improved patient 
 outcome 
• BG < 7.0 mmol/L = increased OR 
• No hypo (BG < 4.0 mmol/L) = increased OR 
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2) Is there a glycemic target band performance metric or level 
that can be assessed in real time that ensures and 
discriminates improved patient outcome? 
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After 3 days… 
 Lower CI bound < 1.0 for Days 1-3 
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3) When should glycemic control performance be assessed? 
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Thank you for your attention 
Questions? 
